Steven Fineberg, MD, presented the study at the Meeting.
BMP is used in more than half of the anterior lumbar fusions in the U.S. and about one third of posterior lumbar fusions. Patients receiving the drug are typically younger with fewer comorbidities, according to the report.
More Articles on Supply Chain:
Benvenue Medical Concludes Patient Follow-Ups in Orthopedic Device Clinical Trial
Medtronic to Eliminate 2k Jobs Worldwide
Blue Belt Technologies, DJO Surgical Partner for Knee Implant System
